The Journal of Immunology, Vol 144, Issue 11 4183-4188, Copyright © 1990 by American Association of Immunologists

ARTICLES

Relative inefficiency of soluble recombinant CD4 for inhibition of infection by monocyte-tropic HIV in monocytes and T cells

PJ Gomatos, NM Stamatos, HE Gendelman, A Fowler, DL Hoover, DC Kalter, DS Burke, EC Tramont and MS Meltzer
Department of Cellular Immunology, Walter Reed Army Institute of Research, Washington, D.C. 20307-5100.

Macrophages are major viral reservoirs in the brain, lungs, and lymph nodes of HIV-infected patients. But not all HIV isolates infect macrophages. The molecular basis for this restrictive target cell tropism and the mechanisms by which HIV infects macrophages are not well understood: virus uptake by CD4-dependent and -independent pathways have both been proposed. Soluble rCD4 (sCD4) binds with high affinity to gp 120, the envelope glycoprotein of HIV, and at relatively low concentrations (less than 1 microgram/ml) completely inhibits infection of many HIV strains in T cells or T cell lines. HTLV-IIIB infection of the H9 T cell line was completely inhibited by prior treatment of virus with 10 micrograms/ml sCD4: no p24 Ag or HIV-induced T cell syncytia were detected in cultures of H9 cells exposed to 1 x 10(4) TCID50 HTLV-IIIB in the presence of sCD4. Under identical conditions and at a 100-fold lower viral inoculum, 10 micrograms/ml sCD4 had little or no effect on infection of monocytes by any of six different HIV isolates by three different criteria: p24 Ag release, virus-induced cytopathic effects, and the frequency of infected cells that express HIV-specific mRNA. At 10- to 100-fold higher concentrations of sCD4, however, infection was completely inhibited. Monoclonal anti-CD4 also prevented infection of these same viral isolates in monocytes. The relative inefficiency of sCD4 for inhibition of HIV infection in monocytes was a property of the virion, not the target cell: HIV isolates that infect both monocytes and T cells required similarly high levels of sCD4 (100 to 200 micrograms/ml) for inhibition of infection. These data suggest that the gp120 of progeny HIV derived from macrophages interacts with sCD4 differently than that of virions derived from T cells. For both variants of HIV, however, the predominant mechanism of virus entry for infection is CD4-dependent.

This article has been cited by other articles:

				E. R. Arganaraz, M. Schindler, F. Kirchhoff, M. J. Cortes, and J. Lama Enhanced CD4 Down-modulation by Late Stage HIV-1 nef Alleles Is Associated with Increased Env Incorporation and Viral Replication J. Biol. Chem., September 5, 2003; 278(36): 33912 - 33919. [Abstract] [Full Text] [PDF]

				R. Wyatt and J. Sodroski The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens Science, June 19, 1998; 280(5371): 1884 - 1888. [Abstract] [Full Text]

				E. O. Freed and M. A. Martin The Role of Human Immunodeficiency Virus Type 1 Envelope Glycoproteins in Virus Infection J. Biol. Chem., October 13, 1995; 270(41): 23883 - 23886. [Full Text] [PDF]

				S. A. Lipton and H. E. Gendelman Dementia Associated with the Acquired Immunodeficiency Syndrome N. Engl. J. Med., April 6, 1995; 332(14): 934 - 940. [Full Text] [PDF]

				S. Hwang, T. Boyle, H. Lyerly, and B. Cullen Identification of envelope V3 loop as the major determinant of CD4 neutralization sensitivity of HIV-1 Science, July 24, 1992; 257(5069): 535 - 537. [Abstract] [PDF]